EW
REGN icon

Evoke Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Evoke Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,150
Closed -$889K – 499
2026
Q1 		$889K Buy
1,150
+340
+42% +$260K 0.02% 293
2025
Q4 		$625K Buy
810
+211
+35% +$143K 0.01% 345
2025
Q3 		$337K Buy
+599
New +$339K 0.01% 481
2023
Q3 		– Sell
-309
Closed -$222K – 397
2023
Q2 		$222K Buy
+309
New +$238K 0.01% 326
2022
Q4 		– Sell
-77
Closed -$53K – 962
2022
Q3 		$53K Sell
77
-2
-3% -$1.26K ﹤0.01% 510
2022
Q2 		$47K Buy
79
+8
+11% +$5.2K ﹤0.01% 525
2022
Q1 		$50K Buy
71
+14
+25% +$8.86K ﹤0.01% 525
2021
Q4 		$36K Sell
57
-1
-2% -$615 ﹤0.01% 578
2021
Q3 		$35K Buy
58
+47
+427% +$29.2K ﹤0.01% 554
2021
Q2 		$6K Hold
11
– – ﹤0.01% 842
2021
Q1 		$5K Buy
11
+4
+57% +$1.95K ﹤0.01% 861
2020
Q4 		$3K Sell
7
-3
-30% -$1.62K ﹤0.01% 836
2020
Q3 		$6K Buy
10
+3
+43% +$1.82K ﹤0.01% 637
2020
Q2 		$4K Hold
7
– – ﹤0.01% 743
2020
Q1 		$3.42K Sell
7
-10
-59% -$4.13K ﹤0.01% 696
2019
Q4 		$6.38K Sell
17
-6
-26% -$2.02K ﹤0.01% 859
2019
Q3 		$6.38K Buy
+23
New +$6.81K ﹤0.01% 938

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Evoke Wealth's REGN Position: Q2 2026 in Review

Evoke Wealth sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 1,150 shares — an estimated $889K sold.

Evoke Wealth first reported a position in REGN in Q3 2019 and held it in 17 quarters. The position peaked at $889K in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Evoke Wealth reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,150 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $889K.
  • Evoke Wealth first reported a position in Regeneron Pharmaceuticals in Q3 2019 and held it in 17 quarters.
  • Evoke Wealth's Regeneron Pharmaceuticals position peaked at $889K in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.